Pma Antibody (BDI183): sc-57977
- Pma Antibody (BDI183) is a mouse monoclonal IgG3 provided at 100 µg/ml
- raised against Pma of human origin
- recommended for detection of human prostate mucin antigen (PMA) of human origin by WB and IF; non cross-reactive with fetal or benign prostate specimens, non-prostate carcinomas and normal human tissue
- At present, we have not yet completed the identification of the preferred secondary detection reagent(s) for Pma Antibody (BDI183). This work is in progress.
QUICK LINKS
SEE ALSO...
Pma Antibody (BDI183) is a mouse monoclonal IgG3 antibody that detects prostate mucin antigen (Pma) in human samples through western blotting (WB) and immunofluorescence (IF) applications. Anti-Pma antibody (BDI183) specifically targets a high molecular weight glycoprotein that is predominantly expressed in prostate carcinomas and cow submaxillary glands, making Pma (BDI183) antibody a valuable marker for prostate cancer diagnosis and monitoring. The unique structure of Pma, characterized by its O-linked oligosaccharide containing N-acetyl galactosamine, contributes to mucin-like properties, which are significant for its role in tumor biology. This glycoprotein′s expression is associated with the progression of prostate cancer, as Pma may facilitate tumor cell adhesion and metastasis, thereby highlighting Pma′s potential as a useful tumor marker in clinical settings. Anti-Pma antibody (BDI183) enables researchers to gain insights into the molecular mechanisms underlying prostate cancer and improve diagnostic accuracy, ultimately aiding in the development of targeted therapies.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Pma Antibody (BDI183) | sc-57977 | 100 µg/ml | $316.00 |